Nanobiotix Takes A Big Step, VRTX Broadens Pipeline, PFE Aims High With Javelin

French nanomedicine company Nanobiotix SA (NANO.PA) has reported successful results from its phase I/II trial of its lead product, NBTXR3, in head and neck cancer.

from RTT - Biotech http://ift.tt/29onUBi
via IFTTT